Safety and efficacy of the PI3Kδ inhibitor zandelisib in combination with the BTK inhibitor zanubrutinib in patients with relapsed/refractory (R/R) follicular lymphoma (FL) or mantle cell lymphoma (MCL) Meeting Abstract
| Authors: | Soumerai, J. D.; Diefenbach, C. S.; Samaniego, F.; Kumar, A.; Tsai, M. L.; Asch, A. S.; Jagadeesh, D.; Kenkre, V. P.; Lossos, I. S.; Salman, H.; Awan, F. T.; Miao, L.; Ghalie, R. G.; Zelenetz, A. D. |
| Abstract Title: | Safety and efficacy of the PI3Kδ inhibitor zandelisib in combination with the BTK inhibitor zanubrutinib in patients with relapsed/refractory (R/R) follicular lymphoma (FL) or mantle cell lymphoma (MCL) |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 189 |
| End Page: | 191 |
| Language: | English |
| ACCESSION: | WOS:000893223200079 |
| DOI: | 10.1182/blood-2022-157563 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
